AstraZeneca - 25 Year Stock Price History | AZN

Historical daily stock prices for AstraZeneca since 1993 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for AstraZeneca (AZN) as of July 18, 2018 is 37.33.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $92.564B $22.465B
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $346.390B 16.55
Pfizer (PFE) United States $224.125B 13.79
Novartis AG (NVS) Switzerland $182.384B 15.80
Merck (MRK) United States $168.593B 15.07
AbbVie (ABBV) United States $151.404B 15.44
Novo Nordisk (NVO) Denmark $122.519B 20.30
Sanofi (SNY) France $105.189B 13.31
GlaxoSmithKline (GSK) United Kingdom $102.004B 13.95
Eli Lilly (LLY) United States $97.222B 19.30
Bristol-Myers Squibb (BMY) United States $92.564B 18.21